1. Clinical, Genetic, and Disability Profile of Pediatric Distal Hereditary Motor Neuropathy
- Author
-
Manoj P. Menezes, Marina Frasquet, Kayla M.D. Cornett, Joshua Burns, Teresa Sevilla, Gabrielle Donlevy, and Herminia Argente-Escrig
- Subjects
Cytoplasmic Dyneins ,Male ,0301 basic medicine ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Neural Conduction ,Disease ,GTP Phosphohydrolases ,Mitochondrial Proteins ,Muscular Atrophy, Spinal ,Disability Evaluation ,03 medical and health sciences ,Grip strength ,0302 clinical medicine ,Sensation ,Intellectual disability ,medicine ,Clinical genetic ,Humans ,Child ,Muscle, Skeletal ,Retrospective Studies ,business.industry ,Retrospective cohort study ,medicine.disease ,Magnetic Resonance Imaging ,Phenotype ,030104 developmental biology ,Child, Preschool ,Mutation ,Cohort ,Female ,Neurology (clinical) ,business ,Microtubule-Associated Proteins ,Motor neuropathy ,030217 neurology & neurosurgery - Abstract
ObjectiveTo describe the clinical, genetic, and disability profile of pediatric distal hereditary motor neuropathy (dHMN) and to determine the utility of an outcome measure validated for children with Charcot-Marie-Tooth disease (CMT) in assessing disability in this cohort.MethodsWe reviewed the clinical, neurophysiologic, and disability data on individuals with dHMN, evaluated before the age of 20 years, at 2 tertiary neuromuscular clinics in Australia and Spain. Disability was assessed annually with the CMT Pediatric Scale (CMTPedS) in a subset of individuals.ResultsTwenty-two children (13 female) from 19 families were included. Fourteen individuals were symptomatic in the first year of life. Intellectual disability was present in 6 individuals; upper motor neuron signs were seen in 8. Pathogenic variants were found in 9 families, more frequently inBICD2(BICD2-4,DYNC1H1-2,MFN2-2,GARS-1). A novel pathogenic variant in theGARSgene was detected and characterized phenotypically. Disability was moderate on the CMTPedS (mean [SD] 18.2 [6.3], n = 16), with balance and long jump being the most affected and sensation items and grip strength the least affected. Over 1 year, the CMTPedS total score deteriorated, on average 1.5 points (SD 3.7) or 9% (n = 12), with significant variability in the rate of progression within the cohort.ConclusionsThe genetic profile of pediatric dHMN is different from that identified in adult cohorts. This study has identified distinct functional limitations for the CMTPedS in children and adolescents with dHMN.
- Published
- 2020